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A fifteen-year experience with carotid
endarterectomy after a formal operative
protocol requiring highly frequent patch
angioplasty
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Purpose: The early and late outcomes of carotid endarterectomy (CEA) following a rigid
protocol of patch angioplasty or occasionally interposition bypass grafting, when the
arteriotomy required to obtain a complete internal carotid end point extended distal to
the bulb segment, and primary closure, when it was limited to the bulb, were studied.
Methods: From November 1983 to August 1998, 1360 consecutive primary CEAs were per-
formed on 1133 patients (621 men, 512 women), with a mean age of 67 years. Of these
patients, 3.8% (51) had primary closure, 66.4% (903) had greater saphenous vein patch
angioplasty, 28.4% (386) had synthetic (359 Dacron, 27 polytetrafluoroethylene) patch
angioplasty, and 1.4% (20) had vein interposition bypass grafting procedures. Indications
were transient ischemic attack in 34.7% of patients (472), stroke in 16.6% of patients (226),
nonlateralizing symptoms in 10.9% of patients (148), and asymptomatic stenosis 70% or
greater in 37.8% of patients (514). The mean follow-up period was 4.6 years.
Results: The 30-day mortality rate was 1.0% (13 patients; 11 cardiac-related deaths, 2
strokes). The 30-day stroke rate was 1.3% (18 patients; 13 ipsilateral strokes, 5 major, 8
minor). The combined 30-day stroke and death rate was 2.1%. Four of the strokes (1
death) were caused by the hyperperfusion syndrome. The 30-day ipsilateral major stroke
or mortality rate was 1.2% (16 patients). The 30-day rate of ipsilateral major stroke or
death from stroke was 0.4% (5 patients). There were two synthetic and one vein patch
internal carotid occlusions in 30 days. Synthetic-patched CEAs were predicted by means
of Cox proportional hazards analysis to have higher risk ratios than saphenous vein-
patched CEAs for early and late stroke (1.3; 95% CI, 1.7 to 1.0; P = .04), for 50% or
greater restenosis (2.4; 95% CI, 3.4 to 1.6; P < .001), and for 70% or greater restenosis
(2.5; 95% CI, 3.6 to 1.7; P < .001). The cumulative mortality rate (Kaplan-Meier) was
13% at 5 years and 31% at 10 years. The cumulative stroke rate was 7% at 5 years and 14%
at 10 years. The 50% or greater restenosis rate was higher in women than in men at 5
years (9% versus 5%; P = .02, Wilcoxon), but tended to equalize later. The 50% or greater
restenosis rate was higher in synthetic-patched CEAs than in saphenous vein-patched
CEAs (12% versus 1% at 1 year; 17% versus 3% at 4 years; and 24% versus 10% at 8 years;
P < .001 by means of log-rank and Wilcoxon). Restenosis after 5 years was more fre-
quently located in the distal common carotid artery (13 of 20 cases). Late reoperations
were more frequent and occurred earlier in synthetic-patched CEAs (eight cases at a mean
of 1.6 years) than vein-patched CEAs (14 cases at a mean of 6.9 years; P = .01). No
strokes and one restenosis of 50% or greater occurred in the 51 primarily closed CEAs.
Conclusion: Patch angioplasty reconstruction of CEAs with arteriotomies that extend
distal to the carotid bulb gives excellent early and long-term outcomes. Saphenous vein-
patched CEAs are superior to synthetic patched CEAs for stroke and restenosis preven-
tion. Primary closure is safe and durable when complete end points and arteriotomies
are within the carotid bulb. (J Vasc Surg 2000;31:724-35.)
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More than two decades ago, Sundt and Imparato
recognized that carotid endarterectomy (CEA) patch
angioplasty reconstruction with autologous greater
saphenous vein improved patients’ outcomes.1,2 Other
authors also reported better results with patch recon-
struction than with primary closure.3-6 Subsequently, a
number of small prospective randomized trials com-
paring patch angioplasty with primary closure were
carried out, with mixed results.7-12 However, meta-
analysis of the pooled data from these trials indicates
the statistically powerful advantage of obligatory patch
angioplasty over obligatory primary closure for early
postoperative internal carotid occlusions, perioperative
stroke, and 50% or greater restenosis at 1 year.13-15
Analysis of studies containing a nonrandomized mix of
primarily closed and patched CEAs suggests that the
higher the incidence of patching, the lower the peri-
operative stroke rate.14 Although the popularity of
CEA patch reconstruction has grown in the last
decade, the choice of patch material has become con-
troversial. Recent reports suggest saphenous vein may
be superior to synthetic materials.16,17 Further, pooled
meta-analysis data indicate that autologous greater
saphenous vein-patched CEAs have a significantly
lower incidence of perioperative stroke and early
restenosis than do Dacron- and polytetrafluoroethyl-
ene (PTFE)-patched CEAs.18,19 If patch angioplasty
reconstruction is advisable for most CEAs and autolo-
gous greater saphenous vein is the optimal patch mate-
rial, it is important to establish the early and long-term
outcomes of this approach.
Beginning in November 1983 and continuing to
date, a formal protocol of primary CEA reconstruc-
tion has been uniformly followed. Obligatory patch
angioplasty, or rarely interposition bypass grafting, is
used when the arteriotomy required to obtain a
complete internal carotid end point extends distal to
the bulb segment. Primary closure is performed only
when a complete feathered end point is obtained in
the bulb segment, with an arteriotomy that does not
extend beyond the bulb, an infrequent event. The
favorable early outcome of the first 100 CEAs per-
formed that followed this protocol has been report-
ed.4 A 3-year follow-up analysis of a recent subset of
Dacron- and greater saphenous vein-patched CEAs
indicates that restenosis is higher in Dacron-patched
CEAs and that the eversion plication shortening of
redundant endarterectomized internal carotid artery
segments may lead to restenosis.17 Although these
early results are included, the purpose of this report
is to define the perioperative, short- and long-term
outcomes for the entire series of primary CEAs per-
formed following the protocol.
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METHODS AND MATERIALS
Patient demographics, risk factors, and
anatomy. From November 1983 to August 1998,
1360 consecutive primary CEAs were performed by
the author, who followed a strict operative protocol
of patch angioplasty, or rarely interposition bypass
grafting, when the arteriotomy required to obtain a
complete internal carotid end point extended distal
to the bulb segment, and primary closure (PC),
when it was limited to the bulb. Of the 1360 CEAs,
621 (134 bilateral) were performed on men, and
512 (93 bilateral) were performed on women. The
mean patient age was 67.5 ± 9.0 years (mean ± SD),
slightly higher in women (68.4 ± 9.3 years) than in
men (66.9 ± 8.8 years). There were 671 right CEAs
and 689 left CEAs. The indications for CEA were
transient ischemia attacks in 473 cases (34.7%),
completed nondebilitating stroke in 226 cases
(16.6%), nonlateralizing or global symptoms in 148
cases (10.9%), and asymptomatic 70% or greater
diameter stenosis in 514 cases (37.8%). One hun-
dred thirty-eight (26.8%) of the 514 CEAs for
asymptomatic stenosis were the second sides of bilat-
eral CEAs, the first side of which was the source of
symptoms in 65 cases and asymptomatic in 73 cases.
Systemic risk factors included previous or current
cigarette smoking in 1080 patients (79.4%), hyper-
tension in 823 patients (60.5%), known coronary
artery disease in 921 patients (67.7%), of whom 128
patients (9.4%) had previously undergone coronary
artery bypass grafting procedures, and diabetes mel-
litus in 186 patients (13.7%).
Preoperative standard or arterial digital arteriog-
raphy was performed on most patients. In 237 more
recently treated patients, the degree of stenosis was
determined by means of duplex ultrasound scan-
ning, occasionally supplemented by magnetic reso-
nance angiography. The operated carotid diameter
stenosis was 77.9% ± 21.9%. The contralateral inter-
nal carotid artery was occluded in 98 patients (67
men, 31 women). Excluding these patients, the con-
tralateral carotid stenosis was 33.1% ± 29.8%.
During this time, 19 internal carotid arteries were
found to be small or poorly visualized (string sign)
by means of arteriography. Of these, eight carotid
arteries were either occluded or small and fibrotic
with low flow and were not repaired. These eight
carotid arteries are not included in this series, nor are
any isolated procedures performed on the external
carotid artery when the internal carotid was occlud-
ed.
CEA was performed concurrent with coronary
bypass grafting procedures before opening the ster-
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num in 73 patients (5.4%). Four patients had com-
bined infrarenal aortic procedures and CEA, and
two patients had combined lower-extremity bypass
grafting procedures and CEA. Ipsilateral vertebral
artery transposition to the common carotid artery
was performed in seven cases.
Operative management. General anesthesia was
used for all operations, except eight operations that
were performed with a regional block. Saphenous
veins were harvested from the groin/thigh in most
women and below the knee/ankle in men. Standard
surgical techniques, including careful dissection
before occlusion, optical magnification, systemic
heparin, and meticulous deep media endarterectomy
and end point management, were used. Jugular
venous and carotid stump back pressure were mea-
sured in all procedures, and a shunt was inserted in
156 cases (9.6%) when the mean cerebral perfusion
pressure (mean stump minus mean venous pressure)
was less than 18 mm Hg. The criteria for not shunt-
ing when perfusion pressure was 18 mm Hg or
greater have been strictly followed for 20 years and
were derived to ensure a collateral blood flow of 18
mL/min/100 g or greater.20 The mean systemic
arterial pressure was 81.7 ± 13.4 mm Hg; the mean
stump pressure was 43.2 ± 16.8 mm Hg; the mean
jugular venous pressure was 5.8 ± 3.2 mm Hg; and
the mean cerebral perfusion pressure was 37.4 ±
16.8 mm Hg. For the 98 CEAs (7.2%) with con-
tralateral internal carotid occlusion, the mean perfu-
sion pressure was 24.4 mm Hg, compared with 38.6
mm Hg when the CEA was patent (P < .001). The
arteriotomy required to achieve a complete internal
carotid endarterectomy end point was within the
bulb segment in 51 CEAs (3.8%), and all these were
primarily closed. The arteriotomy extended into the
uniform diameter internal carotid in the other 1309
CEAs, of which 903 CEAs (66.4%) had patch recon-
struction with autologous greater saphenous vein,
386 CEAs (28.4%) had synthetic patch reconstruc-
tion (359 Dacron, 27 PTFE), and 20 CEAs (1.4%)
had saphenous vein interposition bypass grafts. The
latter were used in the rare cases in which the
endarterectomized segment was extremely long or
severely damaged by disease or endarterectomy.
Internal carotid end point tacking sutures were used
in 33 CEAs (2.4%). Eversion plication shortening of
the endarterectomized internal carotid segment was
performed in 156 CEAs (11.5%). Most of these
were performed in Dacron-patched CEAs. When I
began frequent use of Dacron in 1994, I noticed
that this patch material resulted in a much higher
incidence of kinking distally. Accordingly, shortening
was performed more often.17 Table I gives the recon-
struction methods used in 2- to 3-year intervals.
Intraoperative bidirectional continuous-wave
Doppler ultrasound scanning interrogation was
done after all CEA reconstructions. When the exter-
nal carotid was occluded or had low flow, it was iso-
lated and repaired.21 A significant kink or other
technical major defect was noted in the internal
carotid after six CEAs, and these were reconstructed
a second time to eliminate the problem.
Postoperatively all patients were monitored with
electrocardiography and radial arterial blood pres-
sure readings overnight. Systolic blood pressure was
maintained at 160 mm Hg or less. Beginning in
1990, all patients with severe ipsilateral headache
were observed for the hyperperfusion syndrome,
and hypertension was treated aggressively. In spite of
these occasional patients, the mean postoperative
hospital stay was reduced from an earlier mean of
3.7 days to 1.6 days after 1994. Patients with clear
or questionable perioperative neurologic events
were examined by a neurologist and underwent a
duplex scan, an arteriogram, or both and either a
computed tomography or magnetic resonance imag-
ing scan. All patients who awoke from general anes-
thesia with a new, unexplained neurological defect
and patients in whom a deficit developed before dis-
charge and who had abnormal results on a duplex
scan or arteriogram were reexplored.
Table I. Time course of operations by reconstruction type
Years 1983 to 1985 1986 to 1987 1988 to 1989 1990 to 1991 1992 to 1993 1994 to 1995 1995 to 1998 Total
All 235 205 166 178 200 199 177 1360
Primary closure 12 6 12 6 2 8 5 51
Patch–all 222 190 151 172 196 187 171 1289
Saphenous vein 217 182 133 150 155 59 7 903
Dacron 5 7 1 15 39 128 164 359
PTFE 0 1 17 7 2 0 0 27
Vein interposition 1 9 3 0 2 4 1 20
bypass grafting
PTFE, Polytetrafluoroethylene.
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A drain was placed at all operations. Protamine
was given in the operating room only when there was
excessive bleeding. The incidence of excessive bleed-
ing was approximately 5% and occurred primarily in
patients who had been on Coumadin or one of the
newer antiplatelet drugs preoperatively. Protamine
was given in the recovery room in approximately 8%
of patients in whom there was excessive but not
alarming drainage or mild hematoma formation.
Only nine patients (0.7%) were returned to the oper-
ating room for excessive hemorrhage.
Follow-up. Patients were routinely seen in the
office 6 to 10 days after CEA. Duplex scanning was
advised at 2 months, 6 months, and then annually
(Ultra Mark 8 and later Ultra Mark 9, Advanced
Technology Laboratories, Bothell, Wash). Criteria
for residual or restenosis were: for 50% to 69%
stenosis, a peak systolic velocity of 160 cm/s or
more and spectral broadening; for 70% or greater
stenosis, a peak systolic velocity of 250 cm/s or
more and an end-diastolic velocity of 90 cm/s or
more. All data were prospectively stored in a com-
puter registry. Letters requesting the patients’ cur-
rent status and recommending duplex scanning were
sent annually to surviving patients.
Statistical methods. For categorical variables, the
proportion of CEAs with stroke and recurrent stenosis
was compared with and without specified characteris-
tics or risk factors. The 95% CIs for proportions were
computed from the normal distribution when the
numerator was 5 or more. When the numerator was
less than 5, the binomial distribution was used.
Differences in proportions were tested with either a
two-tailed Fisher exact test or chi-square analysis. In
addition, the probability of stroke and recurrent steno-
sis, with and without specific characteristics or risk fac-
tors, was analyzed by means of Kaplan-Meier survival
analysis with P values by means of log-rank (long
term) and Wilcoxon (short term) methods and/or
Cox proportional hazards analysis. Continuous vari-
ables were analyzed with unpaired Student t tests or
analysis of variance. Those characteristics and risk fac-
tors that had P values near or less than .05 by means
of univariant analysis were subjected to multivariant
analysis with logistic regression and/or Cox propor-
tional hazards analysis to obtain odds or risk ratios and
the 95% CI. Summary statistics are given as mean ±
1SD. All data were prospectively stored in a computer
registry, and statistics were computed with JMP 3.0
software (SAS Institute, Cary, NC).
RESULTS
Perioperative stroke and mortality. The 30-
day hospital and posthospital death and stroke rates,
Table II. Perioperative hospital and posthospital 30-day death and stroke rate for 1360 carotid endarterec-
tomies
Hospital Posthospital All 30-day
N % (± 95% CI) N % (± 95% CI) N % (± 95% CI)
Death
All 9 0.7% (0.4%) 4 0.3% (0.2%) 13 1.0% (0.5%)
Cardiac 8 0.6% (0.4%) 3 0.2% (0.1%) 11 0.8% (0.5%)
Stroke 1 0.07% (0.05%) 1 0.07% (0.05%) 2 0.1% (0.07%)
Stroke*
All 11 0.8% (0.5%) 7 0.5% (0.4%) 18 1.3% (0.6%)
Ipsilateral 8 0.6% (0.4%) 5 0.4% (0.3%) 13 1.0% (0.5%)
Major 3 0.2% (0.17%) 2 0.1% (0.07%) 5 0.4% (0.3%)
Minor 5 0.4% (0.3%) 3 0.2% (0.1%) 8 0.6% (0.4%)
Ipsilateral stroke etiology
ICA thrombosis 0 – 0 – 0 –
Operative embolic 4 0.3% (0.2%) – – – –
Shunt embolic† 2 0.1% (0.07%) – – – –
Hyperperfusion 0 – 4 0.3% (0.2%) 4 0.3% (0.2%)
Unknown‡ 2 0.1% (0.07%) 1 0.07% (0.05%) 3 0.2% (0.5%)
Ipsilateral stroke type reconstruction
Vein (n = 903) 3 0.2% (0.5%) 4 0.3% (0.2%) 7 0.5% (0.4%)
Dacron (n = 359) 5 0.4% (0.3%) 1 0.07% (0.05%) 6 0.45% (0.35%)
PTFE (n = 27) 0 – 0 – 0 –
Bypass (n = 20) 0 – 0 – 0 –
Primary closure (n = 51) 0 – 0 – 0 –
*Includes two stroke-related deaths. 
†Emboli seen in shunt.
‡Normal results on duplex scan or arteriogram.
ICA, Internal carotid artery; PTFE, polytetrafluoroethylene.
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including the etiology of stroke and the type of
reconstruction, are given in Table II. There were 13
(1.0%) 30-day deaths, 11 of which were cardiac-
related (two with concomitant coronary artery
bypass grafting) and two were from stroke. Of the
11 30-day perioperative cardiac-related deaths, nine
occurred between 1983 and 1990 (695 CEAs), and
the other two occurred between 1991 and 1998
(665 CEAs; P = .084). There were 18 strokes (1.3%)
in 30 days, 13 of which were ipsilateral, four were
contralateral (one with coronary artery bypass graft-
ing), and one was posterior. Four of the strokes (one
death) were caused by the hyperperfusion syndrome.
Overall, this syndrome developed in eight patients
(0.6%) from 4 to 8 days after CEA. This small sub-
set of patients was characterized as having high-
grade stenosis (mean, 87%; P < .01 when compared
with other CEAs) and low carotid stump back pres-
sure (mean, 27 mm Hg; P < .001 when compared
with other CEAs). Hemorrhage was found with
computed tomography or magnetic resonance imag-
ing scanning in only one of these eight patients. Five
of the eight ipsilateral hospital strokes were identi-
fied immediately on the patient’s awakening from
general anesthesia. Four of these patients had both
normal results on a duplex scan and an operative
explanation. In two patients, atheroemboli were
seen in the shunt after placement. One patient had a
preoperatively unrecognized atherosclerotic ulcer
approximately 1 cm distal to the stenosis in the
internal carotid artery, which was manipulated
before clamping, and in one patient plaque was visu-
alized in the clamp at the origin of the external
carotid during isolated repair after an occluded
external carotid was indicated by means of intraop-
erative Doppler interrogation.21 The fifth patient
was reoperated on and found to have platelet throm-
bus on a Dacron patch. Four of the seven ipsilateral
strokes in the vein-patched CEA group were caused
by the hyperperfusion syndrome. The incidence of
nonhyperperfusion ipsilateral perioperative stroke in
the vein-patched group was 0.3% (3 of 903
patients), significantly less than 1.7% (6 of 359
patients) for patients with Dacron-patched CEAs (P
= .022). For nonshortened CEAs, the incidence of
nonhyperperfusion ipsilateral perioperative stroke
was 0.3% (3 of 873 patients) for vein-patched CEAs,
significantly less than the 2.1% (5 of 234 patients)
for Dacron-patched CEAs (P = .014). Two of the six
patients who had ipsilateral strokes in the Dacron-
patched CEA group had an unstable neurological
status and underwent semiurgent operations.
Minor perioperative morbidity. Nineteen
(0.8%) ipsilateral transient ischemic attacks were
identified, seven of which were identical to preoper-
ative symptoms. All patients had a duplex scan, 13 of
which were normal, including the seven discussed
earlier; four patients had a 2 mm or greater
endarterectomy-produced common carotid artery
step,22 and two patients had a kink in the internal
carotid at the distal end of a patch. None of these
patients had a stroke, and one patient with a kink
underwent a reoperation for progression to 80%
diameter stenosis 2 years after primary CEA.
Thirteen nonfatal myocardial infarctions occurred,
six of which were subendocardial. Eleven of these
patients subsequently underwent coronary artery
bypass grafting procedures. Cervical/cranial nerve
dysfunction occurred in 10 patients (0.7%). Two
recurrent laryngeal nerve injuries were permanent,
and five were transient. Two transient and one per-
manent hypoglossal nerve injuries and one greater
auricular nerve injury occurred. Ventricular 
tachyarrhythmias occurred in four patients and were
managed medically. Clinically significant hematomas
or drainage necessitating operative exploration
occurred in nine patients (0.6%). Of these cases, two
were caused by saphenous vein patch rupture, one
from suture hole bleeding of a PTFE patch and one
from a repair of the external carotid artery. The
other five patients had no identified source of bleed-
ing at re-exploration. No neck infections occurred.
Eight patients had minor vein harvest incision infec-
tions, six in the thigh and two in the lower leg.
Saphenous vein patch rupture. As previously
reported, central vein patch rupture occurred after
three CEAs.23,24 One rupture occurred in the oper-
ating room, one occurred in the hospital, and one
occurred after discharge. All patients underwent suc-
cessfully reoperations. Only the patient in whom the
rupture occurred after discharge had a minor stroke
that resolved. After 1990, veins with less than 3.5
mm distended diameters were not used, and there
have been no ruptures.24
Long-term stroke and mortality. The 10-year
Kaplan-Meier survival analysis is given in Fig 1
(Table III). Although the etiology of late death was
primarily cardiac-related, in many patients it was dif-
ficult to determine from the communication with
their primary care physicians and/or families. The
10-year Kaplan-Meier analysis of all strokes is given
in Fig 2 (Table IV). Although perioperative ipsilat-
eral stroke was clearly identifiable from contralateral
or posterior territory stroke, this clarification was
not possible for some patients who had late strokes.
Univariant analysis of the possible role of sex, sys-
temic risk factors (smoking, hypertension, diabetes
mellitus, and coronary artery disease), indications
for operation, and the technical/reconstructive vari-
ables (closure type, patch material, internal carotid
shortening, internal carotid tack sutures, use of a
shunt, and combined CEA and cardiac surgery) on
early and late stroke indicated that only sex and
patch material had a P value less than .10. By means
of Cox proportional hazards analysis, women were
predicted to have a slightly higher relative risk ratio
for stroke than men (1.03; 95% CI, 1.09 to 0.97; P
= .29). By means of Cox analysis, Dacron-patched
CEAs were predicted to have a higher risk ratio for
stroke than saphenous vein-patched CEAs (1.3; 95%
CI, 1.7 to 1.0; P = .04).
For patients in whom the side of the stroke was
known, stroke was found to be more frequent on
the ipsilateral side of patients undergoing unilateral
CEA than on the contralateral side by means of Cox
analysis (risk ratio, 3.4; 95% CI, 6.4 to 1.9; P <
.001). Patients undergoing bilateral operations had a
slightly but significantly higher risk ratio for stroke
than those undergoing unilateral CEA (1.10; 95%
CI, 1.18 to 1.03; P = .005). Finally, contralateral
occlusion did not significantly increase stroke risk,
when compared with patients having unilateral CEA
with patent contralateral internal carotids (1.18;
95% CI, 2.27 to 0.73; P = .54).
Residual and recurrent stenosis. Table V gives
the univariant analysis of 50% or greater residual
stenosis detected less than 4 months after CEA, and
the 50% or greater and 70% or greater early recur-
rent stenosis 4 months to 3 years after CEA for the
reconstruction types and patch materials used. Three
early asymptomatic internal carotid occlusions
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 4 Archie 729
occurred, two in Dacron-patched CEAs and one in
a vein-patched CEA. All four residual stenoses were
caused by kinking at the distal end of a patch. One
of these residual stenoses was identified intraopera-
tively by means of continuous-wave Doppler scan-
ning, but was not repaired. The Kaplan-Meier analy-
sis for 50% or greater and 70% or greater recurrent
stenosis for men and women is given in Fig 3 (Table
VI) and Fig 4 (Table VII). The Kaplan-Meier analy-
sis for 50% or greater and 70% or greater recurrent
stenosis for saphenous vein-patched, synthetic-
patched, and primarily closed CEAs is given in Fig 5
(Table VIII) and Fig 6 (Table IX). Although syn-
thetic-patched CEAs have a tendency to restenose
early, restenosis in vein-patched CEAs is prevalent
after 5 years. However, because most synthetic patch-
es were placed after 1993, the follow-up after 5 years
in this subset is insufficient to draw conclusions for
late restenosis. Synthetic-patched CEAs were predict-
ed by means of Cox proportional hazards analysis to
have significantly higher relative risk ratios than vein-
patched CEAs for 50% or greater restenosis (2.4; 95%
CI, 3.4 to 1.6; P < .0001) and for 70% or greater
restenosis (2.5; 95% CI, 3.6 to 1.7; P < .001).
Restenosis after 5 years was most commonly located
in the distal common carotid near the endarterecto-
my-produced step (13 of 20 cases).
The influence of eversion plication shortening of
the redundant endarterectomized internal carotid
segment has been previously analyzed for the CEAs
performed from 1992 to 1997 with saphenous vein-
and Dacron-patch angioplasty.17 The slightly larger
Fig 1. Kaplan-Meier life-table analysis of survival after the
30-day postoperative period. Fig 2. Kaplan-Meier life-table analysis of all strokes after
the 30-day postoperative period.
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numbers of shortened CEAs in the current series
have similar high 50% or greater restenosis rates in
the first 3 years after CEA. Of the 903 vein-patched
CEAs, 30 (3.3%) were shortened, whereas 125 of the
359 Dacron-patched CEAs (35%) were shortened.
No difference in 50% or greater restenosis existed at
3 years for shortened (0) versus unshortened (5)
vein-patched CEAs (P = .8), or for shortened (11)
versus unshortened (10) Dacron-patched CEAs (P =
.13). However, by means of univariant analysis, the
50% or greater restenosis rate at 3 years for shortened
CEAs (11 of 155, 7.1%) versus unshortened CEAs
(15 of 1007, 1.5%) was significant (P < .001).
DISCUSSION
The perioperative, intermediate, and long-term
outcomes reported in this study support the highly
frequent use of patch angioplasty reconstruction of
standard CEAs, following a protocol of using prima-
ry closure only when a complete internal carotid end
point is obtained with an arteriotomy limited to the
bulb segment. The 30-day perioperative mortality of
1.0% ± 0.5% (95% CI), stroke rate of 1.3% ± 0.6%,
ipsilateral stroke rate of 1.0% ± 0.5%, combined all
stroke and mortality rate of 2.1% ± 0.3%, and major
ipsilateral stroke or death rate of 0.4% ± 0.3% are all
within the accepted upper threshold for CEA out-
comes for both symptomatic and asymptomatic
patients. Further, these 30-day outcomes are three-
to five-times better than those of the North
American Symptomatic Carotid Endarterectomy
Trial (NASCET) studies25,26 and equal to the excel-
lent results of the Asymptomatic Carotid
Atherosclerosis (ACAS) study.27 The cumulative
stroke rates of 7% at 5 years and 14% at 10 years and
the cumulative mortality rates of 13% at 5 years and
31% at 10 years are similar to that reported in other
studies.28,29 The restenosis rates are low and have a
bimodal distribution in the first 2 years, and again
after 5 years. Univariant and Cox proportional haz-
ards analyses indicate that only sex (women more
than men) and patch material (synthetics more than
saphenous vein) significantly influenced late stroke
and restenosis outcomes.
The 1983 to 1998 distribution of 30-day deaths
is of interest. During the first half of this study, nine
cardiac-related deaths occurred, compared with only
two cardiac-related deaths during the second half or
the study (P = .08). Although not statistically signif-
icant, this suggests improved anesthetic manage-
Table III. Kaplan-Meier life-table for survival after 30-day postoperative period (Fig 1)
Years Cumulative survival Cumulative mortality Standard error Mortality Censored At risk
0.0000 1.0000 0.0000 0.0000 0 205 1146
0.5000 0.9745 0.0255 0.0051 24 236 941
1.0000 0.9645 0.0355 0.0063 7 176 681
2.0000 0.9529 0.0471 0.0078 6 127 498
3.0000 0.9346 0.0654 0.0103 7 72 365
4.0000 0.9052 0.0948 0.0139 9 75 286
5.0000 0.8962 0.1038 0.0151 2 56 202
6.0000 0.8713 0.1287 0.0191 4 49 144
7.0000 0.8426 0.1574 0.0247 3 31 91
8.0000 0.8278 0.1722 0.0283 1 14 57
9.0000 0.8081 0.1919 0.0338 1 17 42
10.0000 0.7744 0.2256 0.0462 1 10 24
Table IV. Kaplan-Meier life-table for stroke-free intervals 30-day postoperative period (Fig 2)
Years Cumulative stoke-free Cumulative stroke Standard error Stroke Censored At risk
0.0000 1.0000 0.0000 0.0000 0 200 1119
0.5000 0.9869 0.0131 0.0037 12 237 919
1.0000 0.9781 0.0219 0.0052 6 172 670
2.0000 0.9682 0.0318 0.0068 5 128 492
3.0000 0.9520 0.0480 0.0093 6 76 359
4.0000 0.9417 0.0583 0.0110 3 74 277
5.0000 0.9228 0.0772 0.0142 4 59 200
6.0000 0.9026 0.0974 0.0181 3 48 197
7.0000 0.8816 0.1184 0.0230 2 31 86
8.0000 0.8650 0.1350 0.0279 1 13 53
9.0000 0.8428 0.1572 0.0349 1 16 39
10.0000 0.8428 0.1572 0.0349 0 9 22
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ment and/or better preoperative evaluation and
treatment of coronary artery disease. Although I
only refer for cardiology examination those patients
who have symptoms of angina pectoris or congestive
heart failure, I have noted an increasing trend for
patients to have had an earlier examination, coro-
nary angioplasty, or bypass grafting procedure. Only
two stroke-related 30-day deaths occurred, one of
which was caused by hyperperfusion. Three of the
13 30-day deaths occurred after discharge, support-
ing the concept that reporting only hospital deaths
underestimates the true perioperative incidence.
Of the 18 (1.3%) 30-day strokes, 13 were ipsilat-
eral and five were major or disabling. Seven strokes
(five ipsilateral, two major ipsilateral) occurred after
discharge. Both of the major strokes were caused by
the hyperperfusion syndrome. Nonhyperperfusion-
related ipsilateral perioperative strokes were more
frequent in the Dacron-patched CEA subset (1.7%)
than in the saphenous vein patched CEA subset
(0.3%; P = .02). This is similar to my earlier findings,
those of Hertzer et al, and meta-analysis.16-19
In the first 3 months after CEA, only three inter-
nal carotid occlusions (two Dacron, one vein patch)
were identified, all asymptomatic. Four nonocclusive
50% or greater residual stenoses occurred, all caused
Table V. Residual 50% or greater stenosis and early 50% or greater and 70% or greater restenosis after
1360 carotid endarterectomies
6 months to 3 years (%)
50% or greater 70% or greater
Reconstruction (n) 1 to 3 months (%) restenosis restenosis
Primary closure (51) 0 1 (2.0%) 1 (2.0%)
Vein patch (903) 3 (0.3%, 2 kinks, 1 occlusion) 5 (0.6%) 3 (0.3%)
Dacron patch (359) 4 (1.1%, 3 kinks, 1 occlusion) 21 (5.7%) 11 (3.1%)
PTFE patch (27) 0 1 (3.7%) 0
Vein bypass (20) 0 1 (5.0%) 0
All (1360) 7 (0.5%) 29 (2.1%) 15 (1.1%)
P < .001 for vein- versus Dacron-patched carotid endarterectomy and vein- versus synthetic-patched carotid endarterectomy for 50% or
greater and 70% or greater restenosis at 6 months to 3 years.
PTFE, Polytetrafluoroethylene.
Table VI. Kaplan-Meier life-table for 50% or greater restenosis-free intervals for men and women (Fig 3)
Cumulative Cumulative Standard 
Years restenosis-free restenosis error Restenosis Censored At risk
Men
0.0000 1.0000 0.0000 0.0000 0 164 747
0.5000 0.9931 0.0069 0.0034 4 151 583
1.0000 0.9839 0.0161 0.0057 4 109 428
2.0000 0.9776 0.0224 0.0072 2 100 315
3.0000 0.9730 0.0270 0.0085 1 47 213
4.0000 0.9671 0.0329 0.0103 1 51 165
5.0000 0.9671 0.0329 0.0103 0 36 113
6.0000 0.8792 0.1208 0.0330 7 25 77
7.0000 0.8792 0.1208 0.0330 0 18 45
8.0000 0.8466 0.1534 0.0451 1 5 27
9.0000 0.7257 0.2743 0.0753 3 3 21
10.0000 0.6773 0.3227 0.0844 1 6 15
Women
0.0000 1.0000 0.0000 0.0000 0 111 593
0.5000 0.9876 0.0124 0.0051 6 124 482
1.0000 0.9595 0.0405 0.0100 10 95 352
2.0000 0.9478 0.0522 0.0120 3 53 247
3.0000 0.9280 0.0720 0.0153 4 41 191
4.0000 0.9089 0.0911 0.0185 3 36 146
5.0000 0.9004 0.0996 0.0202 1 33 107
6.0000 0.9004 0.0996 0.0202 0 28 73
7.0000 0.8804 0.1196 0.0280 1 12 45
8.0000 0.8804 0.1196 0.0280 0 13 32
9.0000 0.6951 0.3049 0.0853 4 7 19
10.0000 0.6082 0.3918 0.1103 1 2 8
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by kinks at or distal to the toe of a patch. These
were, in theory, preventable by adequate operative
technique and/or identification and revision. The
rate of restenosis 50% or greater within 3 years of
CEA was very low in vein-patched CEAs (0.6%), but
significantly higher in both Dacron- (6.4%) and
PTFE-patched (3.7%) CEAs. These results are simi-
lar to those obtained by meta-analysis.18,19 As was
frequently demonstrated in other studies, women
had a higher rate of early restenosis than did men.
However, the cumulative incidence of restenosis 5
years after CEA was similar in men and women.
Similarly, the cumulative incidence of restenosis in
saphenous vein-patched CEAs increased after 5 years.
Table VII. Kaplan-Meier life-table for 70% or greater restenosis-free intervals for men and women (Fig 4)
Cumulative Cumulative Standard 
Years restenosis-free restenosis error Restenosis Censored At risk
Men
0.0 1.000 0.000 0.000 0 164 747
0.5 0.995 0.005 0.003 3 152 583
1.0 0.992 0.008 0.004 1 112 428
2.0 0.992 0.008 0.004 0 102 315
3.0 0.992 0.008 0.004 0 48 213
4.0 0.992 0.008 0.004 0 52 165
5.0 0.992 0.008 0.004 0 36 113
6.0 0.954 0.046 0.022 3 26 77
7.0 0.934 0.066 0.029 1 20 48
8.0 0.934 0.066 0.029 0 5 27
9.0 0.849 0.151 0.063 2 4 22
10.0 0.849 0.151 0.083 0 8 16
Women
0.0 1.000 0.000 0.000 0 111 593
0.5 0.994 0.006 0.004 3 126 482
1.0 0.974 0.026 0.008 7 99 353
2.0 0.970 0.030 0.009 1 54 247
3.0 0.965 0.035 0.010 1 44 192
4.0 0.952 0.048 0.014 2 36 147
5.0 0.943 0.057 0.016 1 34 109
6.0 0.943 0.057 0.016 0 29 74
7.0 0.943 0.057 0.016 0 13 45
8.0 0.943 0.057 0.016 0 13 32
9.0 0.844 0.156 0.068 2 9 19
10.0 0.738 0.262 0.115 1 2 8
Fig 3. Kaplan-Meier life-table analysis of 50% or greater
restenosis-free intervals for men and women (P = .019 by
means of Wilcoxon test, and P = .087 by means of log-
rank test).
Fig 4. Kaplan-Meier life-table analysis of 70% or greater
restenosis-free intervals for men and women (P = .036 by
means of Wilcoxon test, and P = .071 by means of log-
rank test).
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Fig 5. Kaplan-Meier life-table analysis of 50% or greater
restenosis-free intervals for vein-patched, synthetic-
patched, and primarily closed carotid endarterectomies.
Fig 6. Kaplan-Meier life-table analysis of 70% or greater
restenosis-free intervals for vein-patched, synthetic-
patched, and primarily closed carotid endarterectomies.
Table VIII. Kaplan-Meier life-table for 50% or greater restenosis-free intervals for vein-patched, synthetic-
patched, and primarily closed carotid endarterectomies (Fig 5)
Cumulative Cumulative Standard
Years restenosis-free restenosis error Restenosis Censored At risk
Vein
0.0 1.000 0.000 0.000 0 220 903
0.5 0.994 0.006 0.003 4 125 683
1.0 0.994 0.006 0.003 0 119 554
2.0 0.992 0.008 0.004 1 97 435
3.0 0.986 0.014 0.006 2 64 337
4.0 0.971 0.029 0.009 4 75 271
5.0 0.966 0.034 0.103 1 57 192
6.0 0.923 0.077 0.020 6 44 134
7.0 0.912 0.088 0.022 1 29 84
8.0 0.895 0.105 0.028 1 17 54
9.0 0.796 0.204 0.053 4 9 36
10.0 0.726 0.274 0.067 2 8 23
Synthetic
0.0 1.000 0.000 0.000 0 43 386
0.5 0.985 0.017 0.006 5 141 343
1.0 0.915 0.085 0.019 14 75 197
2.0 0.882 0.118 0.025 4 49 108
3.0 0.833 0.167 0.036 3 23 55
4.0 0.833 0.167 0.036 0 8 29
5.0 0.833 0.167 0.036 0 10 21
6.0 0.758 0.242 0.079 1 6 11
7.0 0.758 0.242 0.079 0 1 4
8.0 0.758 0.242 0.079 0 0 3
9.0 0.000 1.000 0.079 3 0 3
Primary
0.0 1.000 0.000 0.000 0 12 51
0.5 0.974 0.026 0.025 1 9 39
1.0 0.974 0.026 0.025 0 10 29
2.0 0.974 0.026 0.025 0 7 19
3.0 0.974 0.026 0.025 0 1 12
4.0 0.974 0.026 0.025 0 4 11
5.0 0.974 0.026 0.025 0 2 7
6.0 0.974 0.026 0.025 0 3 5
7.0 0.974 0.026 0.025 0 0 3
8.0 0.974 0.026 0.025 0 1 2
9.0 0.974 0.026 0.025 0 1 1
JOURNAL OF VASCULAR SURGERY
734 Archie April 2000
Whether this occurs for synthetic-patched CEAs can-
not be determined by means of this study, because
most of the synthetic-patched CEAs were performed
more recently. The finding that 13 of the 20 ≥ 50%
restenoses occurring after 5 years were located at or
near the endarterectomy-produced common carotid
step supports an earlier report.22
Although there were only 51 (0.4%) primarily
closed CEAs in this study, they performed well, with
no perioperative strokes and only one 50% or greater
restenosis. Primary closure of arteriotomies limited
to the bulb segment with a complete internal carotid
endarterectomy end point is probably safe and advis-
able. On the other end of the spectrum, the 20
(1.5%) complex lesions reconstructed with saphe-
nous vein interposition grafts also had acceptable
outcomes, with no perioperative strokes or occlu-
sions and one late restenosis. There is probably a
place for interposition bypass grafting of complex or
long, extensively diseased carotid arteries.
The CEAs were performed in a 15-year period,
during which there was controversy about the effec-
tiveness of CEA in stroke prevention, followed by
confirmation of its value for both symptomatic and
asymptomatic patients, and most recently, by the
introduction of catheter-based angioplasty with or
without stenting. Although new technology has and
will supersede established vascular surgical tech-
niques, it is imperative that when advising or offer-
ing patients new techniques, or when participating
in prospective randomized trials evaluating them,
physicians must be convinced that, based on current
information, the new technology gives an acceptable
outcome. The 2.1% 30-day stroke and mortality and
the 0.4% major ipsilateral stroke and stroke-related
death rates reported support the argument that stan-
Table IX. Kaplan-Meier life-table for 70% or greater stenosis-free intervals for vein-patched, synthetic-
patched, and primarily closed carotid endarterectomies (Fig 6)
Cumulative Cumulative Standard 
Years restenosis-free failure error Restenosis Censored At risk
Vein
0.0 1.000 0.000 0.000 0 220 903
0.5 0.996 0.004 0.002 3 126 683
1.0 0.996 0.004 0.002 0 119 554
2.0 0.996 0.004 0.002 0 98 435
3.0 0.993 0.007 0.004 1 64 337
4.0 0.985 0.015 0.006 2 76 272
5.0 0.980 0.020 0.008 1 58 194
6.0 0.958 0.042 0.015 3 45 135
7.0 0.948 0.052 0.018 1 32 87
8.0 0.948 0.052 0.018 0 17 54
9.0 0.871 0.129 0.046 3 10 37
10.0 0.834 0.166 0.056 1 10 24
Synthetic
0.0 1.000 0.000 0.000 0 43 386
0.5 0.994 0.006 0.004 2 143 343
1.0 0.954 0.046 0.014 8 82 198
2.0 0.945 0.059 0.017 1 51 108
3.0 0.945 0.059 0.017 0 27 56
4.0 0.945 0.059 0.017 0 8 29
5.0 0.945 0.059 0.017 0 10 21
6.0 0.945 0.059 0.017 0 7 11
7.0 0.945 0.059 0.017 0 1 4
8.0 0.945 0.059 0.017 0 0 4
9.0 0.630 0.370 0.358 1 2 3
Primary
0.0 1.000 0.000 0.000 0 12 51
0.5 0.974 0.026 0.025 1 9 39
1.0 0.974 0.026 0.025 0 10 29
2.0 0.974 0.026 0.025 0 7 19
3.0 0.974 0.026 0.025 0 1 12
4.0 0.974 0.026 0.025 0 4 11
5.0 0.974 0.026 0.025 0 2 7
6.0 0.974 0.026 0.025 0 3 5
7.0 0.974 0.026 0.025 0 0 2
8.0 0.974 0.026 0.025 0 1 2
9.0 0.974 0.026 0.025 0 1 1
JOURNAL OF VASCULAR SURGERY
Volume 31, Number 4 Archie 735
dard CEA with highly frequent patch angioplasty
reconstruction gives excellent results. Based on these
results and the 1.2% ± 0.6% (95% CI) meta-analysis
30-day perioperative stroke rates for patched
CEAs,19 it is safe to project that any new technolo-
gy, such as catheter-based balloon angioplasty with
or without stenting, must have a 30-day stroke rate
less than 2% and a stroke and mortality rate less than
3% to be considered a candidate for prospective eval-
uation of long-term restenosis and stroke outcomes.
CEA following a protocol of patch angioplasty
reconstruction when the arteriotomy necessary to
obtain a complete internal carotid endarterectomy end
point extends beyond the bulb segment into the uni-
form diameter internal carotid gives excellent periop-
erative and long-term outcomes. Saphenous vein is
superior to synthetic materials, particularly Dacron, for
patch angioplasty reconstruction. Because of this, I
currently use autologous greater saphenous vein when
it is available, of adequate quality, and has a distended
diameter greater than 3.5 mm. Dacron is an acceptable
patch material when these vein criteria are not met.
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